Validation of the Withings ScanWatch as a Wrist-Worn Reflective Pulse Oximeter: Prospective Interventional Clinical Study

BackgroundA decrease in the level of pulse oxygen saturation as measured by pulse oximetry (SpO2) is an indicator of hypoxemia that may occur in various respiratory diseases, such as chronic obstructive pulmonary disease (COPD), sleep apnea syndrome, and COVID-19. Currently, no mass-market wrist-wor...

Full description

Bibliographic Details
Main Authors: Kirszenblat, Romain, Edouard, Paul
Format: Article
Language:English
Published: JMIR Publications 2021-04-01
Series:Journal of Medical Internet Research
Online Access:https://www.jmir.org/2021/4/e27503
_version_ 1818566515906052096
author Kirszenblat, Romain
Edouard, Paul
author_facet Kirszenblat, Romain
Edouard, Paul
author_sort Kirszenblat, Romain
collection DOAJ
description BackgroundA decrease in the level of pulse oxygen saturation as measured by pulse oximetry (SpO2) is an indicator of hypoxemia that may occur in various respiratory diseases, such as chronic obstructive pulmonary disease (COPD), sleep apnea syndrome, and COVID-19. Currently, no mass-market wrist-worn SpO2 monitor meets the medical standards for pulse oximeters. ObjectiveThe main objective of this monocentric and prospective clinical study with single-blind analysis was to test and validate the accuracy of the reflective pulse oximeter function of the Withings ScanWatch to measure SpO2 levels at different stages of hypoxia. The secondary objective was to confirm the safety of this device when used as intended. MethodsTo achieve these objectives, we included 14 healthy participants aged 23-39 years in the study, and we induced several stable plateaus of arterial oxygen saturation (SaO2) ranging from 100%-70% to mimic nonhypoxic conditions and then mild, moderate, and severe hypoxic conditions. We measured the SpO2 level with a Withings ScanWatch on each participant’s wrist and the SaO2 from blood samples with a co-oximeter, the ABL90 hemoximeter (Radiometer Medical ApS). ResultsAfter removal of the inconclusive measurements, we obtained 275 and 244 conclusive measurements with the two ScanWatches on the participants’ right and left wrists, respectively, evenly distributed among the 3 predetermined SpO2 groups: SpO2≤80%, 80%<SpO2≤90%, and 90%<SpO2. We found a strong association and a high level of agreement between the measurements collected from the devices, with high Pearson correlation coefficients of r=0.944 and r=0.954 on the correlation plots, low Pearson correlation coefficients of r=0.083 (P=.17) and r=0.23 (P=.001) on Bland-Altman plots, biases of 0.98% (95% CI 0.65-1.32) and 1.56% (95% CI 1.24-1.87), and root mean square errors of 2.97% and 3.00% from the participants’ right and left hands, respectively. ConclusionsIn conclusion, the Withings ScanWatch is able to measure SpO2 levels with adequate accuracy at a clinical grade. No undesirable effects or adverse events were reported during the study. Trial RegistrationClinicalTrials.gov NCT04380389; http://clinicaltrials.gov/ct2/show/NCT04380389
first_indexed 2024-12-14T01:54:41Z
format Article
id doaj.art-25aeb1ffaa4949988855e24117c332e8
institution Directory Open Access Journal
issn 1438-8871
language English
last_indexed 2024-12-14T01:54:41Z
publishDate 2021-04-01
publisher JMIR Publications
record_format Article
series Journal of Medical Internet Research
spelling doaj.art-25aeb1ffaa4949988855e24117c332e82022-12-21T23:21:15ZengJMIR PublicationsJournal of Medical Internet Research1438-88712021-04-01234e2750310.2196/27503Validation of the Withings ScanWatch as a Wrist-Worn Reflective Pulse Oximeter: Prospective Interventional Clinical StudyKirszenblat, RomainEdouard, PaulBackgroundA decrease in the level of pulse oxygen saturation as measured by pulse oximetry (SpO2) is an indicator of hypoxemia that may occur in various respiratory diseases, such as chronic obstructive pulmonary disease (COPD), sleep apnea syndrome, and COVID-19. Currently, no mass-market wrist-worn SpO2 monitor meets the medical standards for pulse oximeters. ObjectiveThe main objective of this monocentric and prospective clinical study with single-blind analysis was to test and validate the accuracy of the reflective pulse oximeter function of the Withings ScanWatch to measure SpO2 levels at different stages of hypoxia. The secondary objective was to confirm the safety of this device when used as intended. MethodsTo achieve these objectives, we included 14 healthy participants aged 23-39 years in the study, and we induced several stable plateaus of arterial oxygen saturation (SaO2) ranging from 100%-70% to mimic nonhypoxic conditions and then mild, moderate, and severe hypoxic conditions. We measured the SpO2 level with a Withings ScanWatch on each participant’s wrist and the SaO2 from blood samples with a co-oximeter, the ABL90 hemoximeter (Radiometer Medical ApS). ResultsAfter removal of the inconclusive measurements, we obtained 275 and 244 conclusive measurements with the two ScanWatches on the participants’ right and left wrists, respectively, evenly distributed among the 3 predetermined SpO2 groups: SpO2≤80%, 80%<SpO2≤90%, and 90%<SpO2. We found a strong association and a high level of agreement between the measurements collected from the devices, with high Pearson correlation coefficients of r=0.944 and r=0.954 on the correlation plots, low Pearson correlation coefficients of r=0.083 (P=.17) and r=0.23 (P=.001) on Bland-Altman plots, biases of 0.98% (95% CI 0.65-1.32) and 1.56% (95% CI 1.24-1.87), and root mean square errors of 2.97% and 3.00% from the participants’ right and left hands, respectively. ConclusionsIn conclusion, the Withings ScanWatch is able to measure SpO2 levels with adequate accuracy at a clinical grade. No undesirable effects or adverse events were reported during the study. Trial RegistrationClinicalTrials.gov NCT04380389; http://clinicaltrials.gov/ct2/show/NCT04380389https://www.jmir.org/2021/4/e27503
spellingShingle Kirszenblat, Romain
Edouard, Paul
Validation of the Withings ScanWatch as a Wrist-Worn Reflective Pulse Oximeter: Prospective Interventional Clinical Study
Journal of Medical Internet Research
title Validation of the Withings ScanWatch as a Wrist-Worn Reflective Pulse Oximeter: Prospective Interventional Clinical Study
title_full Validation of the Withings ScanWatch as a Wrist-Worn Reflective Pulse Oximeter: Prospective Interventional Clinical Study
title_fullStr Validation of the Withings ScanWatch as a Wrist-Worn Reflective Pulse Oximeter: Prospective Interventional Clinical Study
title_full_unstemmed Validation of the Withings ScanWatch as a Wrist-Worn Reflective Pulse Oximeter: Prospective Interventional Clinical Study
title_short Validation of the Withings ScanWatch as a Wrist-Worn Reflective Pulse Oximeter: Prospective Interventional Clinical Study
title_sort validation of the withings scanwatch as a wrist worn reflective pulse oximeter prospective interventional clinical study
url https://www.jmir.org/2021/4/e27503
work_keys_str_mv AT kirszenblatromain validationofthewithingsscanwatchasawristwornreflectivepulseoximeterprospectiveinterventionalclinicalstudy
AT edouardpaul validationofthewithingsscanwatchasawristwornreflectivepulseoximeterprospectiveinterventionalclinicalstudy